Lunai Bioworks Launches AI Consortium Targeting $1.2B U.S. Defense Contracts
Lunai Bioworks has established the National Chemical Defense Consortium to bid for U.S. government contracts valued between $400 million and $1.2 billion. The initiative leverages a proprietary three-year AI model designed to radically accelerate the development of antidotes against chemical threats.